Treatment of laryngopharyngeal reflux disease: A systematic review

doi:10.12998/wjcc.v7.i19.2995

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19077)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

1388

WORD

322

HTML

13379

Figures (1-1)

370

Tables (1-4)

439

Sum=15898

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

444

Download

598

Sum=1042

Publishing Process of This Article

Item

Count

Browse

1108

Download

1029

Sum=2137

Oct 6, 2019 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Review

World J Clin Cases. Oct 6, 2019; 7(19): 2995-3011
Published online Oct 6, 2019. doi: 10.12998/wjcc.v7.i19.2995

Table 3 Proton pump inhibitor therapeutic schemes used in the current literature

Drugs and duration	Study numbers
4-5 wk
Omeprazole 40mg 1/d	1
Omeprazole 20mg 1/d	3
Omeprazole 40mg 2/d	1
Esomeprazole 20mg 2/d	2
Rabeprazole 10mg 1/d	1
6-7 wk
Pantoprazole 40mg 2/d	1
Pantoprazole 40mg 1/d	2
Lansoprazole 30mg 2/d	1
Omeprazole 20mg 2/d	2
8-9 wk
Omeprazole 40mg 1/d	1
Omeprazole 20mg 2/d	1
Omeprazole 40mg 2/d	1
Esomeprazole 40mg 2/d	1
Esomeprazole 40mg 1/d	2
Esomeprazole 20mg 2/d	2
Esomeprazole 20mg 1/d	1
Lansoprazole 30mg 2/d	1
Lansoprazole 30mg 1/d	2
Rabeprazole 20mg 1/d	1
Rabeprazole 20mg 2/d	1
Rabeprazole 10mg 1/d	1
Pantoprazole 40mg 1/d	2
12 wk
Omeprazole 40mg 1/d	1
Omeprazole 20mg 3/d	1
Omeprazole 20mg 2/d	4
Omeprazole 20mg 1/d	1
Esomeprazole 20mg 2/d	3
Esomeprazole 40mg 2/d	1
Lansoprazole 30mg 2/d	4
Lansoprazole 15mg 2/d	1
Rabeprazole 20mg 2/d	1
Rabeprazole 10mg 1/d	1
Pantoprazole 20 mg 2/d	3
Pantoprazole 40 mg 1/d	1
Pantoprazole 40 mg 2/d	6
16-20 wk
Lansoprazole 30 mg 2/d	2
Esomeprazole 40 mg 2/d	1
Esomeprazole 40 mg 1/d	1
Esomeprazole 20 mg 2/d	1
Rabeprazole 20 mg 2/d	1
Pantoprazole 40 mg 2/d	1
Pantoprazole 40 mg 1/d	1
24 wk
Omeprazole 20 mg 2/d	2
Omeprazole 20 mg 1/d	1
Lansoprazole 30 mg 2/d	3

Citation: Lechien JR, Mouawad F, Barillari MR, Nacci A, Khoddami SM, Enver N, Raghunandhan SK, Calvo-Henriquez C, Eun YG, Saussez S. Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases 2019; 7(19): 2995-3011
URL: https://www.wjgnet.com/2307-8960/full/v7/i19/2995.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i19.2995